![Suicide Risk From Weight-Loss Drugs Prompts More EU Questions](/i/c/7434225d-8019-49e0-e60e-48edc6576aaf.webp)
Suicide Risk From Weight-Loss Drugs Prompts More EU Questions
The European Union’s drugs regulator has asked pharma companies including Novo Nordisk A/S and Eli Lilly & Co.
2023-12-01 23:17
![Altimmune Jumps 66% After Positive Results for Its Obesity Drug](/i/c/33ec74d1-492f-7c7d-ffb4-f240617d6e98.webp)
Altimmune Jumps 66% After Positive Results for Its Obesity Drug
Altimmune Inc. jumped as much as 66% in late trading after the biotech company reported results from a
2023-12-01 07:26
![Long-Time Novo Bull Slashes Stake Citing Weight-Loss Drug Hype](/i/c/32037065-74bb-c443-2df3-4bf6e5acbd1a.webp)
Long-Time Novo Bull Slashes Stake Citing Weight-Loss Drug Hype
A top-performing European fund manager is calling time on “hype” around weight-loss drugs that has sent Novo Nordisk
2023-11-27 16:52
![A Biotech Slump Is Emptying Labs and Threatening Research on New Drugs](/i/c/59688bbc-1963-adc7-546d-013340e896a8.webp)
A Biotech Slump Is Emptying Labs and Threatening Research on New Drugs
Sangamo Therapeutics Inc.’s cost cuts didn’t hurt just the roughly 162 US workers who lost their jobs this
2023-11-22 19:51
![Analysis-Big investors say US markets rally could prove short-lived](/i/c/38aa0f95-c6ac-b0d8-63a6-c4c5d22a3856.webp)
Analysis-Big investors say US markets rally could prove short-lived
By Carolina Mandl, Svea Herbst-Bayliss and David Randall NEW YORK The recent rally that has lifted U.S. stocks
2023-11-22 19:25
![Lilly to build $2.5 billion diabetes drug plant in Germany](/i/c/cdbe7a42-f515-813a-b25d-4b6bcf608723.webp)
Lilly to build $2.5 billion diabetes drug plant in Germany
By Klaus Lauer and Ludwig Burger Eli Lilly will build its first plant in Germany for 2.3 billion
2023-11-17 21:45
![Lilly extends tender offer to acquire Point Biopharma to Dec 1](/i/c/7e15b19b-77e1-102b-6deb-5481207feb5b.webp)
Lilly extends tender offer to acquire Point Biopharma to Dec 1
Eli Lilly said on Friday it was extending the deadline for its tender offer for Point Biopharma shares
2023-11-17 20:21
![Germany Mulls Obesity Drug Export Ban as EU Confronts Shortage](/i/c/891bfe09-7305-a3aa-0e83-a8d4526fb58f.webp)
Germany Mulls Obesity Drug Export Ban as EU Confronts Shortage
Germany is considering an export ban on Novo Nordisk A/S’s blockbuster weight-loss drugs as European countries try to
2023-11-15 18:54
![Novo Shares Rise After Wegovy Demonstrates Heart Benefit in Trial](/i/c/252228df-9dfb-5e13-7107-56da386bdb76.webp)
Novo Shares Rise After Wegovy Demonstrates Heart Benefit in Trial
Novo Nordisk A/S gained another $14.5 billion of market value after a key study backed the use of
2023-11-13 20:54
![One Dose of Lilly’s Novel Heart Drug Cut Risk Factors for a Year](/i/c/7ca1462b-6110-0700-f4bf-1d1d81e81648.webp)
One Dose of Lilly’s Novel Heart Drug Cut Risk Factors for a Year
A single dose of an experimental drug from Eli Lilly & Co. cut by 94% a risk factor
2023-11-13 09:17
![Wegovy Study Bolsters Use In Patients With Obesity and Heart Disease](/i/c/028b34ab-a51e-4fc1-4f5e-d4ba8dad29f8.webp)
Wegovy Study Bolsters Use In Patients With Obesity and Heart Disease
Novo Nordisk A/S unveiled details from a closely watched study that support use of Wegovy, its blockbuster weight-loss
2023-11-11 21:53
![Weight-Loss Drugs Among the Most Sought-After New Corporate Benefits](/i/c/6671c1c1-ea6e-3746-5d05-2f50678ec438.webp)
Weight-Loss Drugs Among the Most Sought-After New Corporate Benefits
The craze around pricey weight-loss drugs has many people clamoring for these treatments in company-sponsored health plans. While
2023-11-11 00:59